Home/ Supplements/ Nac/ Revive

Revive

product on market Capsule FS Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains N-Acetyl Cysteine, Turmeric, and Milk Thistle, which have moderate to strong evidence for supporting liver health and antioxidant activity. Indole-3-Carbinol and Brassaiopsis glomerulata are also included, though research on these specific components is more limited. The overall evidence coverage for this specific combination is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Revive
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 600.0mg (7 products) 39 studies (A:2, B:13)
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
250 mg
Market median: 250.0mg (562 products) 55 studies (A:0, B:19)
Brassaiopsis glomerulata
250 mg
Indole-3-Carbinol
200 mg
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)
Androsta-3,5-Diene-7,17-Dione
75 mg
Bioperine
10 mg

Other Ingredients

Gelatin Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified Structure/Function
Info

Product Information

Formulation Notes

Post cycle therapy 3-in-1 post cycle therapy Naturally boost testosterone Reduce estrogen formulation Enhance liver health

Metadata

Product Details

DSLD Entry Date2020-05-22
Product TypeOther Combinations
FormCapsule
BrandFS
DSLD ID219370
Data Updated2026-04-11
Research

Research Evidence

41
Research Sources
51
Avg Quality
19
Rct
13
Meta Analysis
9
Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024 PubMed DOI
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015 PubMed DOI
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019 PubMed DOI
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 PubMed DOI
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021 PubMed DOI
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020 PubMed DOI
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024 PubMed DOI
View all evidence for Nac →
Compare

Similar Products

View all Nac products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.